Effects of the administration of catecholamine-depleting drugs on the thyroid function of the rat.
D000614:Aminocaproates / Q000494:pharmacology; D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001835:Body Weight; D002395:Catecholamines / Q000037:antagonists & inhibitors*; D003080:Cold Temperature; D006145:Guanethidine / Q000494:pharmacology; D006207:Half-Life; D007031:Hypothalamus / Q000378:metabolism; D007456:Iodine Isotopes; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013747:Tetrabenazine / Q000494:pharmacology; D013961:Thyroid Gland / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D013972:Thyrotropin / Q000378:metabolism
D000614:Aminocaproates; D002395:Catecholamines; D007456:Iodine Isotopes; D008781:Methyltyrosines; D012110:Reserpine; D013972:Thyrotropin; D000661:Amphetamine; D009638:Norepinephrine; D013747:Tetrabenazine; D006145:Guanethidine